Stephen Baxter
Stock Analyst at Wells Fargo
(2.18)
# 2,749
Out of 4,931 analysts
186
Total ratings
38.14%
Success rate
-3.5%
Average return
Main Sectors:
Stocks Rated by Stephen Baxter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNH UnitedHealth Group | Maintains: Overweight | $306 → $267 | $241.13 | +10.73% | 13 | Aug 4, 2025 | |
| MOH Molina Healthcare | Maintains: Overweight | $372 → $216 | $154.81 | +39.53% | 18 | Jul 23, 2025 | |
| CNC Centene | Downgrades: Equal-Weight | $72 → $30 | $25.20 | +19.05% | 22 | Jul 23, 2025 | |
| ELV Elevance Health | Maintains: Overweight | $478 → $400 | $281.04 | +42.33% | 11 | Jul 15, 2025 | |
| OSCR Oscar Health | Downgrades: Underweight | $16 → $10 | $15.00 | -33.33% | 11 | Jul 11, 2025 | |
| PNTG The Pennant Group | Maintains: Equal-Weight | $30 → $31 | $23.97 | +29.33% | 1 | Jun 3, 2025 | |
| MCK McKesson | Maintains: Equal-Weight | $691 → $766 | $656.00 | +16.77% | 6 | Jun 3, 2025 | |
| COR Cencora | Upgrades: Overweight | $274 → $337 | $277.00 | +21.66% | 3 | Jun 3, 2025 | |
| CAH Cardinal Health | Upgrades: Overweight | $136 → $179 | $152.78 | +17.16% | 7 | Jun 3, 2025 | |
| CYH Community Health Systems | Maintains: Underweight | $2 → $3.5 | $2.50 | +40.28% | 9 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $320 → $385 | $371.15 | +3.73% | 14 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $150 → $195 | $161.97 | +20.39% | 13 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 → $27 | $20.23 | +33.47% | 4 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $6 → $5 | $0.83 | +502.12% | 7 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $76 → $84 | $62.97 | +33.40% | 14 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $230 → $225 | $166.62 | +35.04% | 13 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $370 → $341 | $270.20 | +26.21% | 7 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $387 → $290 | $254.37 | +14.01% | 10 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $17 → $15 | $6.95 | +115.83% | 3 | Apr 29, 2024 |
UnitedHealth Group
Aug 4, 2025
Maintains: Overweight
Price Target: $306 → $267
Current: $241.13
Upside: +10.73%
Molina Healthcare
Jul 23, 2025
Maintains: Overweight
Price Target: $372 → $216
Current: $154.81
Upside: +39.53%
Centene
Jul 23, 2025
Downgrades: Equal-Weight
Price Target: $72 → $30
Current: $25.20
Upside: +19.05%
Elevance Health
Jul 15, 2025
Maintains: Overweight
Price Target: $478 → $400
Current: $281.04
Upside: +42.33%
Oscar Health
Jul 11, 2025
Downgrades: Underweight
Price Target: $16 → $10
Current: $15.00
Upside: -33.33%
The Pennant Group
Jun 3, 2025
Maintains: Equal-Weight
Price Target: $30 → $31
Current: $23.97
Upside: +29.33%
McKesson
Jun 3, 2025
Maintains: Equal-Weight
Price Target: $691 → $766
Current: $656.00
Upside: +16.77%
Cencora
Jun 3, 2025
Upgrades: Overweight
Price Target: $274 → $337
Current: $277.00
Upside: +21.66%
Cardinal Health
Jun 3, 2025
Upgrades: Overweight
Price Target: $136 → $179
Current: $152.78
Upside: +17.16%
Community Health Systems
May 29, 2025
Maintains: Underweight
Price Target: $2 → $3.5
Current: $2.50
Upside: +40.28%
May 29, 2025
Upgrades: Equal-Weight
Price Target: $320 → $385
Current: $371.15
Upside: +3.73%
May 29, 2025
Upgrades: Overweight
Price Target: $150 → $195
Current: $161.97
Upside: +20.39%
May 13, 2025
Maintains: Overweight
Price Target: $25 → $27
Current: $20.23
Upside: +33.47%
May 13, 2025
Maintains: Overweight
Price Target: $6 → $5
Current: $0.83
Upside: +502.12%
May 6, 2025
Maintains: Overweight
Price Target: $76 → $84
Current: $62.97
Upside: +33.40%
Mar 10, 2025
Maintains: Overweight
Price Target: $230 → $225
Current: $166.62
Upside: +35.04%
Feb 4, 2025
Maintains: Equal-Weight
Price Target: $370 → $341
Current: $270.20
Upside: +26.21%
Nov 4, 2024
Maintains: Overweight
Price Target: $387 → $290
Current: $254.37
Upside: +14.01%
Apr 29, 2024
Maintains: Equal-Weight
Price Target: $17 → $15
Current: $6.95
Upside: +115.83%